Invicta Diagnostic Limited (NSE:INVICTA)
74.75
-2.25 (-2.92%)
At close: Nov 20, 2026
Invicta Diagnostic Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 34.32 | 49.06 | 48.92 | 37.61 | - | - |
Depreciation & Amortization | 47.1 | 32.4 | 24.87 | 19.21 | - | - |
Other Amortization | 0.07 | 0.07 | 0.04 | 0.12 | - | - |
Other Operating Activities | 4.7 | 6 | 19.73 | 14.31 | - | - |
Change in Accounts Receivable | -8.97 | 8.84 | -6.01 | -8.5 | - | - |
Change in Inventory | 0.17 | -0.91 | -1.09 | -3.94 | - | - |
Change in Accounts Payable | -23.94 | 14.84 | -10.34 | 11.49 | - | - |
Change in Other Net Operating Assets | 18.77 | -80.98 | -10.53 | -6.69 | - | - |
Operating Cash Flow | 72.53 | 29.32 | 65.59 | 63.62 | - | - |
Operating Cash Flow Growth | - | -55.29% | 3.10% | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -196.54 | -129.61 | -5.56 | -84.78 | - | - |
Sale of Property, Plant & Equipment | 0.98 | 0.98 | 2.29 | - | - | - |
Investment in Securities | 0.27 | -18.64 | -43.34 | - | - | - |
Other Investing Activities | 5.13 | 10.56 | -5.69 | -1.2 | - | - |
Investing Cash Flow | -220.74 | -136.71 | -52.3 | -85.98 | - | - |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 24.3 | - | - | - | - |
Long-Term Debt Issued | - | - | - | 38.01 | - | - |
Total Debt Issued | 22.45 | 24.3 | - | 38.01 | - | - |
Long-Term Debt Repaid | - | -22.97 | -2.73 | - | - | - |
Net Debt Issued (Repaid) | -26.13 | 1.33 | -2.73 | 38.01 | - | - |
Issuance of Common Stock | - | - | - | 9.33 | - | - |
Other Financing Activities | 357.2 | 306.58 | -2.3 | -12.07 | - | - |
Financing Cash Flow | 271.06 | 307.91 | -5.03 | 35.28 | - | - |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | - |
Net Cash Flow | 122.86 | 200.52 | 8.26 | 12.92 | - | - |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -124.01 | -100.29 | 60.03 | -21.16 | - | - |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -30.46% | -30.35% | 19.89% | -13.31% | - | - |
Free Cash Flow Per Share | -10.44 | -10.08 | 7.13 | -2.51 | - | - |
Levered Free Cash Flow | - | -107.63 | 46.72 | -11.82 | - | - |
Unlevered Free Cash Flow | - | -106.84 | 47.72 | -11.45 | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 1.95 | 1.95 | 2.3 | 1.01 | - | - |
Cash Income Tax Paid | 10.24 | 10.24 | - | - | - | - |
Change in Working Capital | -13.97 | -58.22 | -27.97 | -7.64 | - | - |